Mary Agnes Wilderotter - Jun 6, 2022 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director
Signature
/s/ James J. MacDonald, Attorney-in-Fact for Mary Agnes Wilderotter
Stock symbol
SANA
Transactions as of
Jun 6, 2022
Transactions value $
$0
Form type
4
Date filed
6/8/2022, 06:36 PM
Previous filing
Jun 6, 2022
Next filing
Jun 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +65K $0.00 65K Jun 6, 2022 Common Stock 65K $4.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2023 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 6, 2022.